Soliqua Dose Titration Increments
Increase Soliqua by 2 to 4 units every week based on fasting plasma glucose levels. This is the FDA-approved titration strategy that balances glycemic control with safety 1.
Specific Titration Algorithm
The FDA label provides clear guidance on weekly dose adjustments 1:
- If fasting glucose is ABOVE target: Increase by +2 to +4 units
- If fasting glucose is WITHIN target: No change (0 units)
- If fasting glucose is BELOW target: Decrease by -2 to -4 units
Each unit adjustment of Soliqua 100/33 contains 1 unit of insulin glargine and 0.33 mcg of lixisenatide. Therefore:
- A 2-unit increase = +2 units insulin glargine + 0.66 mcg lixisenatide
- A 4-unit increase = +4 units insulin glargine + 1.32 mcg lixisenatide
Key Titration Principles
The pen dials in 1-unit increments, allowing precise dose adjustments within the 2-4 unit weekly titration range 1. The dosing range is 15 to 60 units maximum daily dose.
Titrate weekly, not daily. This frequency allows adequate time to assess the metabolic response while avoiding overcorrection that could lead to hypoglycemia 1.
Important Caveats
- More aggressive titration may be needed with changes in physical activity, meal patterns, renal/hepatic function, acute illness, or when adding other medications 1
- Monitor fasting plasma glucose as the primary guide for titration decisions
- Do not split doses - Soliqua must be given as a single daily injection 1
- Maximum dose is 60 units (60 units insulin glargine/20 mcg lixisenatide) 1
This structured approach differs from traditional basal insulin titration (which often uses 2 units every 3 days per ADA guidelines 2) because Soliqua contains both basal insulin and a GLP-1 receptor agonist component that requires coordinated uptitration.